Overview on Causes and Updated Management of Favism
Mohammed Hussen Sheikh *
Department of Pediatric, University of Tabuk, Faculty of Medicine, Saudi Arabia.
Ahlam Shary J. Hazazi
Tabuk University, Saudi Arabia.
Ashwaq Nafea O. Alanazi
Tabuk University, Saudi Arabia.
Ibtisam Shary J. Hazazi
Tabuk University, Saudi Arabia.
Amal Abutaleb M. Qaysi
Tabuk University, Saudi Arabia.
Yara Abdulrahman Alali
Tabuk University, Saudi Arabia.
Badaya Awadh M. Alshehri
Tabuk University, Saudi Arabia.
Ohoud Abdullah Almutari
Tabuk University, Saudi Arabia.
Rawan Hamdi Bedaiwi
Tabuk University, Saudi Arabia.
Rawan Hamoud M. Alatawi
Tabuk University, Saudi Arabia.
Rahf Mohammed Alqarni
Tabuk University, Saudi Arabia.
Alanoud Abdullah Alharbi
King Fahad Specialist Hospital, Qassim, Saudi Arabia.
Rawan Ahmed H. Alshehri
Taif University, Saudi Arabia.
Rinad Rasheed M. Alrashidi
Hail University, Saudi Arabia.
Mona Awad O. Al Balawi
Tabuk University, Saudi Arabia.
*Author to whom correspondence should be addressed.
Abstract
Favism is most common in those who have G6PD deficiency from the Mediterranean region. As hemolytic anaemia is the most common complication of G6PD deficiency, and it can be life-threatening in certain people. Infection, hyperglycemia, certain meals, and certain drugs can all cause hemolysis therefore, the most prevalent enzymopathy is glucose-6-phosphate dehydrogenase (G6PD) deficiency, which affects an estimated 400 million individuals, globally. Exposure to some medicines might cause hemolytic anaemia. The most important management technique is to avoid oxidative stresses by avoiding a hemolytic crisis. Also, avoidance of exposure to food and medicines that causes hemolytic anaemia episodes
This review looks at etiology, epidemiology, pathopysiology, evaluation and management of the disease.
Keywords: Favism, Hemolytic anaemia, glucose-6-phosphate dehydrogenase